370 related articles for article (PubMed ID: 18344436)
1. Tumor blood flow measured by PET dynamic imaging of first-pass 18F-FDG uptake: a comparison with 15O-labeled water-measured blood flow.
Mullani NA; Herbst RS; O'Neil RG; Gould KL; Barron BJ; Abbruzzese JL
J Nucl Med; 2008 Apr; 49(4):517-23. PubMed ID: 18344436
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and patterns of physiologic muscle uptake detected with whole-body 18F-FDG PET.
Jackson RS; Schlarman TC; Hubble WL; Osman MM
J Nucl Med Technol; 2006 Mar; 34(1):29-33. PubMed ID: 16517966
[TBL] [Abstract][Full Text] [Related]
3. Tumor blood flow measured by perfusion computed tomography and 15O-labeled water positron emission tomography: a comparison study.
Ng CS; Kodama Y; Mullani NA; Barron BJ; Wei W; Herbst RS; Abbruzzese JL; Charnsangavej C
J Comput Assist Tomogr; 2009; 33(3):460-5. PubMed ID: 19478644
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the novel myocardial perfusion positron-emission tomography tracer 18F-BMS-747158-02: comparison to 13N-ammonia and validation with microspheres in a pig model.
Nekolla SG; Reder S; Saraste A; Higuchi T; Dzewas G; Preissel A; Huisman M; Poethko T; Schuster T; Yu M; Robinson S; Casebier D; Henke J; Wester HJ; Schwaiger M
Circulation; 2009 May; 119(17):2333-42. PubMed ID: 19380625
[TBL] [Abstract][Full Text] [Related]
5. Myocardial blood flow: comparison of oxygen-15-water bolus injection, slow infusion and oxygen-15-carbon dioxide slow inhalation.
Iida H; Takahashi A; Tamura Y; Ono Y; Lammertsma AA
J Nucl Med; 1995 Jan; 36(1):78-85. PubMed ID: 7799088
[TBL] [Abstract][Full Text] [Related]
6. The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules/masses when compared with 18F-FDG-PET.
Hsieh HJ; Lin SH; Lin KH; Lee CY; Chang CP; Wang SJ
Ann Nucl Med; 2008 Jul; 22(6):533-8. PubMed ID: 18670862
[TBL] [Abstract][Full Text] [Related]
7. 9:30-9:45. First Pass FDG Measured Blood Flow in Tumors: A Comparison with O-15 Labeled Water Measured Blood Flow.
Mullani N; Herbst R; Abbruzzese J; Barron B; Lamki L; Charnsangavej C; Kim E; Tran H; Jiwani A; Gould K
Clin Positron Imaging; 2000 Jul; 3(4):153. PubMed ID: 11150756
[TBL] [Abstract][Full Text] [Related]
8. Giant cell arteritis on 18F-FDG PET/CT.
Heston TF; Szabo Z
Clin Physiol Funct Imaging; 2009 Sep; 29(5):382-4. PubMed ID: 19522856
[TBL] [Abstract][Full Text] [Related]
9. Low-dose quantitative myocardial blood flow imaging using 15O-water and PET without attenuation correction.
Lubberink M; Harms HJ; Halbmeijer R; de Haan S; Knaapen P; Lammertsma AA
J Nucl Med; 2010 Apr; 51(4):575-80. PubMed ID: 20237035
[TBL] [Abstract][Full Text] [Related]
10. Retro-orbital injection is an effective route for radiopharmaceutical administration in mice during small-animal PET studies.
Nanni C; Pettinato C; Ambrosini V; Spinelli A; Trespidi S; Rubello D; Al-Nahhas A; Franchi R; Alavi A; Fanti S
Nucl Med Commun; 2007 Jul; 28(7):547-53. PubMed ID: 17538396
[TBL] [Abstract][Full Text] [Related]
11. Parametric images of blood flow in oncology PET studies using [15O]water.
Lodge MA; Carson RE; Carrasquillo JA; Whatley M; Libutti SK; Bacharach SL
J Nucl Med; 2000 Nov; 41(11):1784-92. PubMed ID: 11079484
[TBL] [Abstract][Full Text] [Related]
12. Estimation of the beta+ dose to the embryo resulting from 18F-FDG administration during early pregnancy.
Zanotti-Fregonara P; Champion C; Trébossen R; Maroy R; Devaux JY; Hindié E
J Nucl Med; 2008 Apr; 49(4):679-82. PubMed ID: 18344434
[TBL] [Abstract][Full Text] [Related]
13. Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.
De Giorgi U; Valero V; Rohren E; Dawood S; Ueno NT; Miller MC; Doyle GV; Jackson S; Andreopoulou E; Handy BC; Reuben JM; Fritsche HA; Macapinlac HA; Hortobagyi GN; Cristofanilli M
J Clin Oncol; 2009 Jul; 27(20):3303-11. PubMed ID: 19451443
[TBL] [Abstract][Full Text] [Related]
14. Tumor volume assessment by 18F-FDG PET/CT in patients with oral cavity cancer with dental artifacts on CT or MR images.
Baek CH; Chung MK; Son YI; Choi JY; Kim HJ; Yim YJ; Ko YH; Choi J; Cho JK; Jeong HS
J Nucl Med; 2008 Sep; 49(9):1422-8. PubMed ID: 18703597
[TBL] [Abstract][Full Text] [Related]
15. [18F]Fluorodeoxyglucose as a memory marker of transient myocardial ischaemia.
Abbott BG; Liu YH; Arrighi JA
Nucl Med Commun; 2007 Feb; 28(2):89-94. PubMed ID: 17198348
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of dual-time-point 18F-FDG PET for staging in patients with lung cancer.
Uesaka D; Demura Y; Ishizaki T; Ameshima S; Miyamori I; Sasaki M; Fujibayashi Y; Okazawa H
J Nucl Med; 2008 Oct; 49(10):1606-12. PubMed ID: 18794269
[TBL] [Abstract][Full Text] [Related]
17. Tissue distribution of 18F-FDG-labeled peripheral hematopoietic stem cells after intracoronary administration in patients with myocardial infarction.
Kang WJ; Kang HJ; Kim HS; Chung JK; Lee MC; Lee DS
J Nucl Med; 2006 Aug; 47(8):1295-301. PubMed ID: 16883008
[TBL] [Abstract][Full Text] [Related]
18. Operational radiation safety for PET-CT, SPECT-CT, and cyclotron facilities.
Zanzonico P; Dauer L; St Germain J
Health Phys; 2008 Nov; 95(5):554-70. PubMed ID: 18849690
[TBL] [Abstract][Full Text] [Related]
19. Real-time iterative monitoring of radiofrequency ablation tumor therapy with 15O-water PET imaging.
Bao A; Goins B; Dodd GD; Soundararajan A; Santoyo C; Otto RA; Davis MD; Phillips WT
J Nucl Med; 2008 Oct; 49(10):1723-9. PubMed ID: 18794264
[TBL] [Abstract][Full Text] [Related]
20. [Inhibition of 18F-FDG uptake in glioblastoma cells by FDG and glucose].
Oehr P; Ruhlmann J; Kozak B; Brock H; Thieme D; Rink H
Acta Med Austriaca; 1999; 26(3):101-3. PubMed ID: 10520378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
